These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


417 related items for PubMed ID: 17117688

  • 1. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
    Reutzel-Edens SM.
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
    [Abstract] [Full Text] [Related]

  • 2. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
    Erdemir D, Lee AY, Myerson AS.
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
    [Abstract] [Full Text] [Related]

  • 3. Polymorph control: past, present and future.
    Llinàs A, Goodman JM.
    Drug Discov Today; 2008 Mar; 13(5-6):198-210. PubMed ID: 18342795
    [Abstract] [Full Text] [Related]

  • 4. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Gardner CR.
    Adv Drug Deliv Rev; 2004 Feb 23; 56(3):275-300. PubMed ID: 14962582
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insight to the thermodynamic stability of molecular crystals through crystallographic studies of a multipolymorph system.
    Ng AT, Lai C, Dabros M, Gao Q.
    J Pharm Sci; 2014 Nov 23; 103(11):3423-3431. PubMed ID: 25252084
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.
    Pasquali I, Bettini R, Giordano F.
    Adv Drug Deliv Rev; 2008 Feb 14; 60(3):399-410. PubMed ID: 17964684
    [Abstract] [Full Text] [Related]

  • 13. IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.
    Pöllänen K, Häkkinen A, Reinikainen SP, Rantanen J, Karjalainen M, Louhi-Kultanen M, Nyström L.
    J Pharm Biomed Anal; 2005 Jun 15; 38(2):275-84. PubMed ID: 15925219
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Application of supercritical solution rapid expansion technology in preparation of fine pharmacal particles].
    Zhang ZY, Li HL, Lei ZJ.
    Zhongguo Zhong Yao Za Zhi; 2006 Dec 15; 31(23):1933-6. PubMed ID: 17348181
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
    Zhang GG, Law D, Schmitt EA, Qiu Y.
    Adv Drug Deliv Rev; 2004 Feb 23; 56(3):371-90. PubMed ID: 14962587
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.